Asia Pacific Blood Brain Barrier Technologies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, and Other Non-Invasive BBB Technologies) and Application (Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, and Others)
Market Introduction
Asia Pacific blood brain barrier technologies market is analyzed based countries such as China, Japan, India, Australia, South Korea, and the rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The growth of the market in this region is expected to grow at a faster pace owing to factors such as large pool of patients, increasing awareness about neurodegenerative disorders, and advancement in technology coupled with growing R&D in developing countries in the Asia Pacific region. Additionally, developing healthcare infrastructure and increasing investments to boost the manufacturing capacities are projected to drive the Asia Pacific blood brain barrier technologies market during the forecast period.
As of September 2021, COVID-19 cases reached 56.5 million in Asia Pacific, according to the United Nations Office for the Coordination of Humanitarian Affairs (UNOCHA). COVID-19 also attacks the brain, which may result in a global or focal neurologic manifestation, according to few studies carried out in Asia. It has been reported that COVID-19 infection can also show several neurologic manifestations, such as ageusia, anosmia, or dysgeusia, and causes neurologic disorders such as stroke, encephalopathy, Guillain-Barre syndrome, and many more. Emerging evidence has revealed that SARS-CoV-2 can affect the central nervous system (CNS) in addition to the respiratory system. Scientists detected SARS-CoV-2 RNA in multiple organs, including post-mortem brain tissue of patients with COVID-19. A recent study of COVID-19 patients following an autopsy showed that SARS-CoV-2 was present in cortical neurons. In addition, the results from human brain organoids also illustrated the neuroinvasion capability of SARS-CoV-2. Together, these data provide evidence for SARS-CoV-2 infection in the human CNS, but how the virus invades the brain is still undiscovered. In few research studies, it has been observed the spike protein of the SARS-CoV-2 virus also crosses the blood brain barrier in several models. As a result, the blood-brain barrier technologies market in the region has seen significant expansion due to the COVID-19 impact.
Get more information on this report : 
Market Overview and Dynamics
The blood brain barrier technologies market in Asia Pacific is expected to grow from US$ 221.98 million in 2021 to US$ 1,123.04 million by 2028; it is estimated to grow at a CAGR of 26.1% from 2021 to 2028. Neurological disorders such as epilepsy and seizures, Parkinson's disease, dementia, autism, Alzheimer's disease, brain tumors, and cerebral palsy, among others affect the brain and nerves of the human body. Epilepsy is a noncommunicable chronic brain disease that affects people of all ages. According to the World Health Organization (WHO), around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases in the world. Almost 80% of people with epilepsy live in low- and middle-income countries. The same source estimates that up to 70% of people with epilepsy could live seizure-free with proper diagnosis and treatment. Dementia is currently the seventh leading cause of death among all diseases and one of the leading causes of disability and addiction in older people worldwide. According to the WHO, more than 55 million people live with dementia worldwide, and there are nearly 10 million new cases every year. Dementia is caused by a variety of diseases and injuries that primarily or secondarily affect the brain. Alzheimer's disease is the most common form of dementia and may contribute to 60–70% of cases. Thus, the growing prevalence of neurological disorders demands advanced blood-brain barrier technologies for the treatment is expected to drive the market during the forecast period.
Key Market Segments
In terms of technology, the increasing permeability segment accounted for the largest share of the Asia Pacific blood brain barrier technologies market in 2021. In terms of application, the parkinson’s disease segment accounted for the largest share of the Asia Pacific blood brain barrier technologies market in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the blood brain barrier technologies market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Teva Pharmaceutical Industries Ltd.; F. Hoffmann-La Roche Ltd.; Eli Lilly and Company; Bristol-Myers Squibb Company; Pfizer, Inc.; Johnson & Johnson Services, Inc.; and JCR Pharmaceuticals Co., Ltd. among others.
Reasons to buy report
- To understand the Asia Pacific blood brain barrier technologies market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific blood brain barrier technologies market
- Efficiently plan M&A and partnership deals in Asia Pacific blood brain barrier technologies market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific blood brain barrier technologies market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.
Asia Pacific Blood Brain Barrier Technologies Market Segmentation
Asia Pacific Blood Brain Barrier Technologies Market – By Technology
- Bispecific Antibody RMT Approach
- Trojan Horse Approach
- Increasing Permeability
- Passive Diffusion
- Other Non-Invasive BBB Technologies
Asia Pacific Blood Brain Barrier Technologies Market – By Application
- Alzheimer’s Disease
- Epilepsy
- Parkinson’s Disease
- Multiple Sclerosis
- Hunter’s Syndrome
- Brain Cancer
- Others
Asia Pacific Blood Brain Barrier Technologies Market – By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Asia Pacific Blood Brain Barrier Technologies Market – Companies Mentioned
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Pfizer, Inc.
- Johnson & Johnson Services, Inc.
- JCR Pharmaceuticals Co., Ltd.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Blood Brain Barrier Technologies Market – By Technology
1.3.2 Asia Pacific Blood Brain Barrier Technologies Market – By Application
1.3.3 Asia Pacific Blood Brain Barrier Technologies Market– By Country
2. Asia Pacific Blood Brain Barrier Technologies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Blood Brain Barrier Technologies Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Asia Pacific Blood Brain Barrier Technologies Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Elevating Prevalence of Neurological Disorders
5.1.2 Boosting Geriatric Population and Rising Prevalence of Age-Associated Neurological Disorders
5.2 Market Restraints
5.2.1 Concerns in Brain Medication Delivery
5.3 Market Opportunities
5.3.1 Huge Number of Product Approvals and Launches
5.4 Future Trends
5.4.1 Growing Demand of Nanoparticles for Brain Drug Delivery
5.5 Impact Analysis
6. Asia Pacific Blood Brain Barrier Technologies – Market Analysis
6.1 Asia Pacific Blood Brain Barrier Technologies Market Revenue Forecast and Analysis
7. Asia Pacific Blood Brain Barrier Technologies Market Analysis – by Technology
7.1 Overview
7.2 Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)
7.3 Bispecific Antibody RMT Approach
7.3.1 Overview
7.3.2 Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Trojan Horse Approach
7.4.1 Overview
7.4.2 Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Increasing Permeability
7.5.1 Overview
7.5.2 Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Passive Diffusion
7.6.1 Overview
7.6.2 Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Other Non-Invasive BBB Technologies
7.7.1 Overview
7.7.2 Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Blood Brain Barrier Technologies Market Analysis – By Application
8.1 Overview
8.2 Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)
8.3 Alzheimer’s Disease
8.3.1 Overview
8.3.2 Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Epilepsy
8.4.1 Overview
8.4.2 Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Parkinson’s Disease
8.5.1 Overview
8.5.2 Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Multiple Sclerosis
8.6.1 Overview
8.6.2 Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Hunter’s Syndrome
8.7.1 Overview
8.7.2 Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Brain Cancer
8.8.1 Overview
8.8.2 Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Blood Brain Barrier Technologies Market – Country Analysis
9.1 Overview
9.1.1 Asia Pacific: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)
9.1.1.1 China: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 China: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 China: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.3 China: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
9.1.1.2 Japan: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 Japan: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 Japan: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.3 Japan: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
9.1.1.3 India: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 India: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 India: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.3 India: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
9.1.1.4 South Korea: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 South Korea: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 South Korea: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.3 South Korea: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
9.1.1.5 Australia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 Australia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 Australia: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.3 Australia: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
9.1.1.6 Rest of Asia Pacific: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Asia Pacific: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Asia Pacific: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.3 Rest of Asia Pacific: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Asia Pacific Blood Brain Barrier Technologies Market
10.1 Impact Assessment of COVID-19 Pandemic
11. Asia Pacific Blood Brain Barrier Technologies Market– Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Teva Pharmaceutical Industries Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Eli Lilly and Company
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bristol-Myers Squibb Company
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pfizer, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Johnson and Johnson Services, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 JCR Pharmaceuticals Co., Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Blood Brain Barrier Technologies Market – Revenue, and Forecast to 2028 (US$ Million)
Table 2. China: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 3. China: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Japan: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. India: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 7. India: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. South Korea: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 9. South Korea: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Australia: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 11. Australia: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of Asia Pacific: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of Asia Pacific: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 14. Organic Developments Done By Companies
Table 15. Inorganic Developments Done By Companies
Table 16. Glossary of Terms, Blood Brain Barrier Technologies Market
LIST OF FIGURES
Figure 1. Asia Pacific Blood Brain Barrier Technologies Market Segmentation
Figure 2. Blood Brain Barrier Technologies Market Segmentation, By Country
Figure 3. Asia Pacific Blood Brain Barrier Technologies Market Overview
Figure 4. Increasing Permeability Segment Held the Largest Share by Technology in Blood Brain Barrier Technologies Market
Figure 5. India to Show Significant Growth During Forecast Period
Figure 6. Asia Pacific Blood Brain Barrier Technologies Market, Industry Landscape
Figure 7. Asia Pacific PEST Analysis
Figure 8. Asia Pacific Blood Brain Barrier Technologies Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 9. Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)
Figure 10. Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)
Figure 16. Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Asia Pacific: Blood Brain Barrier Technologies Market, by Key Country – Revenue (2021) (USD Million)
Figure 24. Asia Pacific: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)
Figure 25. China: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Japan: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. India: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. South Korea: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Australia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Rest of Asia Pacific: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Impact of COVID-19 Pandemic on Asia Pacific Country Markets- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Pfizer, Inc.
- Johnson & Johnson Services, Inc.
- JCR Pharmaceuticals Co., Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific blood brain barrier technologies market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific blood brain barrier technologies market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the blood brain barrier technologies market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution